Published on 1 Mar 2024 on Zacks via Yahoo Finance
For Immediate Release
Chicago, IL – March 1, 2024 – Today, Zacks Equity Research discusses United Therapeutics UTHR, Esperion Therapeutics. ESPR, Heron Therapeutics HRTX, Lyra Therapeutics LYRA and Aldeyra Therapeutics ALDX.
Industry: Drugs - Small & Mid-Sized